Τρίτη 17 Μαΐου 2016

Fitness during Breast Cancer Treatment and Recovery in an Athlete: A Case Study.

Purpose: This is a case study of an aerobically trained, multi-sport, female athlete (age = 39) diagnosed with stage IIIc human epidermal growth factor receptor 2 positive breast cancer. The focus of the study is on measures of cardiorespiratory fitness (VO2peak) through the course of cancer therapy. Methods: A symptom-limited cardiopulmonary exercise tolerance test was performed to determine VO2peak. The test were performed at 5 different time points; 1) at diagnosis of breast cancer and prior to initiating chemotherapy, 2) after completion of chemotherapy (5-months post diagnosis), 3) 2 1/2 months after bilateral mastectomy surgery (9-months post diagnosis), 4) immediately following radiation therapy (11-months post diagnosis), 5) recovery (32 months post diagnosis). Results: At diagnosis and prior to initiating chemotherapy VO2peak was 50.1 mLO2*min-1*kg-1. The most precipitous decline in fitness, approximately 14%, was observed during the period of time from initial diagnosis through the completion of chemotherapy. The subject regained 9% of her fitness after chemotherapy, despite an intervening mastectomy surgery. Radiation therapy was associated with an approximately 4% decline in fitness from her post-mastectomy surgery value. Ultimately, 32 months after diagnosis and 22 months following the completion of radiation therapy, the subject was able to regain pretreatment fitness levels. Conclusion: The results of the case study describe the effects of undergoing extensive breast cancer therapy on measures of VO2peak for a highly aerobically trained, multi-sport athlete. In this case, exercise training reversed the decrement in measured VO2peak that occurred during cancer therapy. (C) 2016 American College of Sports Medicine

from Sports Medicine via xlomafota13 on Inoreader http://ift.tt/27y5k0f
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.